Nanobiotix Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 88
Employees
  • Stock Symbol
  • NANO
Stock Symbol
  • Share Price
  • $14.90
  • (As of Wednesday Closing)

Nanobiotix General Information

Description

Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Stock Exchange
PAR
Primary Office
  • Bâtiment B 60
  • 60 rue de Wattignies
  • 75012 Paris
  • France
+33 01 00 00 00 00

Nanobiotix Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobiotix Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.90 $15.37 $6.54 - $20.94 $513M 34.5M 65K -$1.57

Nanobiotix Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 612,738 612,738 199,781 228,278
Revenue 57 57 76 137
EBITDA (41,267) (41,267) (49,763) (34,119)
Net Income (38,290) (38,290) (56,997) (35,809)
Total Assets 164,852 164,852 62,959 52,843
Total Debt 60,243 60,243 49,877 23,474
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nanobiotix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanobiotix‘s full profile, request access.

Request a free trial

Nanobiotix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its propr
Biotechnology
Paris, France
88 As of 2020
00000
00000000 00000

000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
0000000000000
Lexington, MA
000 As of 0000
00000
000000000 00000

00000000

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanobiotix Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agenus Formerly VC-backed Lexington, MA 000 00000 000000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed Maastricht, Netherlands 00 000.00 0000000000 000.00
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
You’re viewing 5 of 20 competitors. Get the full list »

Nanobiotix Executive Team (14)

Name Title Board Seat Contact Info
Patrick Tricoli Ph.D Chief Executive Officer, USA & Vice President, Corporate Development
Laurent Levy Ph.D Chief Executive Officer & Chairman
Bart Rhijn Chief Financial Officer & Executive Board Member
Philippe Mauberna Ph.D Chief Financial Officer, Finance & Board Member
Alain Dostie Chief Operating Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Nanobiotix Board Members (10)

Name Representing Role Since
Alain Herrera Ph.D Self Board Member & Member of Supervisory Board 000 0000
Anne-Juliette Hermant Nanobiotix Board Member & Executive 000 0000
Anne-Marie Graffin Self Deputy Chairman & Board Member 000 0000
Enno Spillner Self Board Member & Member of Supervisory Board 000 0000
Laurent Condomine Self Chairman of Supervisory Board & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Nanobiotix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial